Forskaren har utsetts till Årets Stockholmsbyggnad

Mer än 4 600 Stockholmare har sagt sitt om vilken som är deras favorit bland huvudstadens alla byggnader. Etta kom Forskaren i Hagastaden.

AI automates testing of implant coatings

The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect coated implants.

FDA approves new cystic fibrosis therapy

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

AZ:s antikroppskonjugat godkänd för ytterligare cancerform

Ett nytt läkemedel mot avancerad icke-småcellig lungcancer har godkänts i USA. Det handlar om Datroway, som tagits fram av AstraZeneca och japanska Daiichi Sankyo.

She is CSL Behring's new Nordic General Manager

Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...

Lundabolag tar in finansiering för utveckling av radionuklidterapi

Spago Nanomedicals styrelse föreslår en nyemission på upp till 30,6 miljoner kronor för att finansiera den fortsatta utvecklingen av bolagets cancerbehandling Tumorad.

Setback for Moderna in patent dispute with mRNA competitors

Moderna has suffered a setback in a patent battle against their worst competitors in covid vaccines, Biontech and its partner Pfizer.

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...

New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...

Conference recordings now available

Don't miss out on insights from leading experts.

Pneumatics Makes a Technological Leap with Piezo

The first high-precision proportional valve terminal VTEP opens up new application areas

ZEISS supports the transition of spatial biology to clinical research

Slide scanner ZEISS Axioscan 7 spatial biology provides scalable workflow automation.

Utvecklar diabetesmedicin – vill ta in 243 miljoner kronor

Diamyd Medical har beslutat att ta in 243 miljoner kronor i en företrädesemission. Något som ska ge möjlighet att "förverkliga alla värden" i företaget, enligt ...

Nya turer om DNA-testbolaget 23andme – grundare tar över

Budstriden om konkursade DNA-testbolaget 23andme och dess biobank med genetisk information verkar nu vara avgjord – och det är bolagets förra vd och medgrundare...

Novo Nordisk to invest billions in Danish manufacturing facilities

Danish pharmaceutical giant Novo Nordisk is investing DKK 42 billion, equivalent to around SEK 65 billion/EUR 5.6 billion, in its manufacturing facilities in Ka...

GSK acquires oncology research company

GSK acquires the American biotechnology company Idrx for up to 1.15 billion dollars.

The Top 10 Challenges Facing Laboratories Today

Navigating the Laboratory Automation Landscape

Mercks RSV-läkemedel får tummen upp i USA – tar upp kampen med Beyfortus

Amerikanska FDA godkänner Mercks nya läkemedel mot infektioner orsakade av RS-virus. Därmed får Sanofis och Astra Zenecas storsäljare Beyfortus ny konkurrens.

Bioscience – Groundbreaking Research & Diagnostics: Gothenburg 2026

LINK Medical recruits Swedish CEO

The Norwegian Contract Research Organization LINK Medical has recruited Anders Göransson as the new CEO.

How to Assure Quality within R&D Medical Devices

Free webinar on June 3rd, 2025, 9:00 - 9:45 AM CEST and 5:00 - 5:45 PM CEST.

A new giant among our microscopes

Two technologies in one machine.

Licensavtal tar Astra Zeneca in i kampen om fetmapatienterna

Astra Zeneca ger sig nu på allvar in på det allt hetare fetmaområdet genom ett licensavtal med kinesiska Eccogene.